Amyotrophic lateral sclerosis: moving towards a new classification system

The Lancet Neurology - Tập 15 Số 11 - Trang 1182-1194 - 2016
Ammar Al‐Chalabi1, Orla Hardiman2, Matthew C. Kiernan3,4, Adriano Chiò5, Benjamin Rix-Brooks6,7, Leonard H. van den Berg8
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King’s College London, London, UK
2Academic Unit of Neurology, Biomedical Sciences Institute, Trinity College Dublin, Ireland
3Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
4Sydney Medical School, University of Sydney, Sydney, NSW, Australia
5‘Rita Levi Montalcini’ Department of Neuroscience, University of Turin, Turin, Italy
6Carolinas Neuromuscular/ALS-MDA Center, Department of Neurology, Carolinas Medical Center, Carolinas Healthcare System Neurosciences Institute, Charlotte, NC, USA
7University of North Carolina School of Medicine—Charlotte Campus, Charlotte, NC, USA
8Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Netherlands

Tóm tắt

Từ khóa


Tài liệu tham khảo

Rutter-Locher, 2016, Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease, Amyotroph Lateral Scler Frontotemporal Degener, 1

Aran, 1850, Recherches sur une maladie non encore décrite du système musculaire (atrophie musculaire progressive), Arch Gén Méd, 24, 172

Cruveilhier, 1853, La paralysie musculaire, progressive, atrophique, Bull Acad Méd, 18, 546

Brain, 1933

Brain, 1962

Mackay, 1963, Course and prognosis in amyotrophic lateral sclerosis, Arch Neurol, 8, 17, 10.1001/archneur.1963.00460020017001

Hu, 1998, Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 65, 950, 10.1136/jnnp.65.6.950

Shoesmith, 2007, Prognosis of amyotrophic lateral sclerosis with respiratory onset, J Neurol Neurosurg Psychiatry, 78, 629, 10.1136/jnnp.2006.103564

Wijesekera, 2009, Natural history and clinical features of the flail arm and flail leg ALS variants, Neurology, 72, 1087, 10.1212/01.wnl.0000345041.83406.a2

Sabatelli, 2008, Natural history of young-adult amyotrophic lateral sclerosis, Neurology, 71, 876, 10.1212/01.wnl.0000312378.94737.45

Turner, 2013, Controversies and priorities in amyotrophic lateral sclerosis, Lancet Neurol, 12, 310, 10.1016/S1474-4422(13)70036-X

Al-Chalabi, 2012, The genetics and neuropathology of amyotrophic lateral sclerosis, Acta Neuropathol, 124, 339, 10.1007/s00401-012-1022-4

Brooks, 1994, J Neurol Sci, 124, 96, 10.1016/0022-510X(94)90191-0

Brooks, 2000, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph Lateral Scler Other Motor Neuron Disord, 1, 293, 10.1080/146608200300079536

de Carvalho, 2008, Electrodiagnostic criteria for diagnosis of ALS, Clin Neurophysiol, 119, 497, 10.1016/j.clinph.2007.09.143

Carvalho, 2009, Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis, Amyotroph Lateral Scler, 10, 53, 10.1080/17482960802521126

Aggarwal, 2008, ALS drug development: reflections from the past and a way forward, Neurotherapeutics, 5, 516, 10.1016/j.nurt.2008.08.002

Chiò, 1999, ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis, J Neurol, 246, III1, 10.1007/BF03161081

Turner, 2009, Biomarkers in amyotrophic lateral sclerosis, Lancet Neurol, 8, 94, 10.1016/S1474-4422(08)70293-X

Boekestein, 2010, Sensitivity and specificity of the ‘Awaji’ electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS, Amyotroph Lateral Scler, 11, 497, 10.3109/17482961003777462

Chen, 2010, Experience with the Awaji Island modifications to the ALS diagnostic criteria, Muscle Nerve, 42, 831, 10.1002/mus.21841

Costa, 2012, Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review, Arch Neurol, 69, 1410, 10.1001/archneurol.2012.254

Douglass, 2010, An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease, J Neurol Neurosurg Psychiatry, 81, 646, 10.1136/jnnp.2009.197434

Gawel, 2014, Are we really closer to improving the diagnostic sensitivity in ALS patients with Awaji criteria?, Amyotroph Lateral Scler Frontotemporal Degener, 15, 257, 10.3109/21678421.2014.887118

Krarup, 2011, Lower motor neuron involvement examined by quantitative electromyography in amyotrophic lateral sclerosis, Clin Neurophysiol, 122, 414, 10.1016/j.clinph.2010.06.027

Okita, 2011, Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria?, J Neurol Sci, 302, 29, 10.1016/j.jns.2010.12.007

Schrooten, 2011, Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study, Ann Neurol, 70, 79, 10.1002/ana.22380

Jang, 2015, AWAJI criteria are not always superior to the previous criteria: a meta-analysis, Muscle Nerve, 51, 822, 10.1002/mus.24575

Rodrigues, 2013, Sharing ontology between ICD 11 and SNOMED CT will enable seamless re-use and semantic interoperability, Stud Health Technol Inform, 192, 343

Rodrigues, 2015, Semantic alignment between ICD-11 and SNOMED CT, Stud Health Technol Inform, 216, 790

Kingdon, 2010, A diagnostic system using broad categories with clinically relevant specifiers: lessons for ICD-11, Int J Soc Psychiatry, 56, 326, 10.1177/0020764010367864

Kaji, 2015, Ultra-high dose methylcobalamin (E0302) prolongs survival of ALS: report of 7 years' randomised double-blind, phase 3 clinical trial, Neurology, 84, 10.1212/WNL.84.14_supplement.P7.060

Neuwirth, 2016, Quality control of Motor Unit Number Index (MUNIX) measurements in 6 muscles in a single-subject “round-robin” setup, PLoS ONE, 11, e0153948, 10.1371/journal.pone.0153948

Tartaglia, 2007, Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up, Arch Neurol, 64, 232, 10.1001/archneur.64.2.232

Turner, 2010, The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis, J Neurol Sci, 294, 81, 10.1016/j.jns.2010.03.028

Visser, 2007, Disease course and prognostic factors of progressive muscular atrophy, Arch Neurol, 64, 522, 10.1001/archneur.64.4.522

van den Berg-Vos, 2003, Sporadic lower motor neuron disease with adult onset: classification of subtypes, Brain, 126, 1036, 10.1093/brain/awg117

Ludolph, 2015, A revision of the El Escorial criteria - 2015, Amyotroph Lateral Scler Frontotemporal Degener, 16, 291, 10.3109/21678421.2015.1049183

Gordon, 2006, The natural history of primary lateral sclerosis, Neurology, 66, 647, 10.1212/01.wnl.0000200962.94777.71

Short, 2005, A case of presumptive primary lateral sclerosis with upper and lower motor neurone pathology, J Clin Neurosci, 12, 706, 10.1016/j.jocn.2004.08.032

Le Forestier, 2001, Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature, Brain, 124, 1989, 10.1093/brain/124.10.1989

Brugman, 2009, Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes, Arch Neurol, 66, 509, 10.1001/archneurol.2009.19

Van den Berg-Vos, 2009, A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes, Arch Neurol, 66, 751, 10.1001/archneurol.2009.91

Vucic, 2007, Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 78, 849, 10.1136/jnnp.2006.105056

Swash, 2012, Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis?, J Neurol Neurosurg Psychiatry, 83, 659, 10.1136/jnnp-2012-302315

Menon, 2015, Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study, Lancet Neurol, 14, 478, 10.1016/S1474-4422(15)00014-9

Vucic, 2011, Cortical excitability distinguishes ALS from mimic disorders, Clin Neurophysiol, 122, 1860, 10.1016/j.clinph.2010.12.062

Chiò, 2011, Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study, J Neurol Neurosurg Psychiatry, 82, 740, 10.1136/jnnp.2010.235952

Burrell, 2011, Isolated bulbar phenotype of amyotrophic lateral sclerosis, Amyotroph Lateral Scler, 12, 283, 10.3109/17482968.2011.551940

Hu, 2009, Survival profiles of patients with frontotemporal dementia and motor neuron disease, Arch Neurol, 66, 1359, 10.1001/archneurol.2009.253

Lomen-Hoerth, 2003, Are amyotrophic lateral sclerosis patients cognitively normal?, Neurology, 60, 1094, 10.1212/01.WNL.0000055861.95202.8D

Phukan, 2012, The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study, J Neurol Neurosurg Psychiatry, 83, 102, 10.1136/jnnp-2011-300188

Montuschi, 2015, Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy, J Neurol Neurosurg Psychiatry, 86, 168, 10.1136/jnnp-2013-307223

Bensimon, 1994, A controlled trial of riluzole in amyotrophic lateral sclerosis, N Engl J Med, 330, 585, 10.1056/NEJM199403033300901

Johnston, 2006, Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London, J Neurol, 253, 1642, 10.1007/s00415-006-0195-y

Harold, 2009, Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, Nat Genet, 41, 1088, 10.1038/ng.440

Turner, 2012, Young-onset amyotrophic lateral sclerosis: historical and other observations, Brain, 135, 2883, 10.1093/brain/aws144

Proudfoot, 2016, The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset, Amyotroph Lateral Scler Frontotemporal Degener, 17, 414, 10.3109/21678421.2016.1140786

Knibb, 2016, A clinical tool for predicting survival in ALS, J Neurol Neurosurg Psychiatry, 10.1136/jnnp-2015-312908

Gordon, 2010, Progression in ALS is not linear but is curvilinear, J Neurol, 257, 1713, 10.1007/s00415-010-5609-1

Rooney, 2014, An exploratory spatial analysis of ALS incidence in Ireland over 17·5 years (1995–July 2013), PLoS ONE, 9, e96556, 10.1371/journal.pone.0096556

Ravits, 2009, ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration, Neurology, 73, 805, 10.1212/WNL.0b013e3181b6bbbd

Brettschneider, 2014, Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD), Acta Neuropathol, 127, 423, 10.1007/s00401-013-1238-y

Schmidt, 2016, Simulating disease propagation across white matter connectome reveals anatomical substrate for neuropathology staging in amyotrophic lateral sclerosis, Neuroimage, 124, 762, 10.1016/j.neuroimage.2015.04.005

Elamin, 2015, Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm, J Neurol, 262, 1447, 10.1007/s00415-015-7731-6

Byrne, 2011, Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis, J Neurol Neurosurg Psychiatry, 82, 623, 10.1136/jnnp.2010.224501

Ganesalingam, 2009, Latent cluster analysis of ALS phenotypes identifies prognostically differing groups, PLoS ONE, 4, e7107, 10.1371/journal.pone.0007107

McCluskey, 2014, ALS-Plus syndrome: non-pyramidal features in a large ALS cohort, J Neurol Sci, 345, 118, 10.1016/j.jns.2014.07.022

Brooks, 2014, ALS-Plus – where does it begin, where does it end?, J Neurol Sci, 345, 1, 10.1016/j.jns.2014.07.027

Brettschneider, 2012, Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis, Acta Neuropathol, 123, 395, 10.1007/s00401-011-0932-x

Cardenas-Blanco, 2014, Central white matter degeneration in bulbar- and limb-onset amyotrophic lateral sclerosis, J Neurol, 261, 1961, 10.1007/s00415-014-7434-4

Cistaro, 2012, Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset, Eur J Nucl Med Mol Imaging, 39, 251, 10.1007/s00259-011-1979-6

Prell, 2013, Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis, Clin Neurol Neurosurg, 115, 1281, 10.1016/j.clineuro.2012.11.031

Canosa, 2016, 18F-FDG-PET correlates of cognitive impairment in ALS, Neurology, 86, 44, 10.1212/WNL.0000000000002242

Byrne, 2012, Absence of consensus in diagnostic criteria for familial neurodegenerative diseases, J Neurol Neurosurg Psychiatry, 83, 365, 10.1136/jnnp-2011-301530

Byrne, 2011, Proposed criteria for familial amyotrophic lateral sclerosis, Amyotroph Lateral Scler, 12, 157, 10.3109/17482968.2010.545420

Byrne, 2013, Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis, Ann Neurol, 74, 699, 10.1002/ana.23969

Al-Chalabi, 2011, Modelling the effects of penetrance and family size on rates of sporadic and familial disease, Hum Hered, 71, 281, 10.1159/000330167

Al-Chalabi, 2010, An estimate of amyotrophic lateral sclerosis heritability using twin data, J Neurol Neurosurg Psychiatry, 81, 1324, 10.1136/jnnp.2010.207464

Wroe, 2008, ALSOD: the Amyotrophic Lateral Sclerosis Online Database, Amyotroph Lateral Scler, 9, 249, 10.1080/17482960802146106

Kenna, 2013, Using reference databases of genetic variation to evaluate the potential pathogenicity of candidate disease variants, Hum Mutat, 34, 836, 10.1002/humu.22303

Hanby, 2011, The risk to relatives of patients with sporadic amyotrophic lateral sclerosis, Brain, 134, 3454, 10.1093/brain/awr248

DeJesus-Hernandez, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011

Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010

Shatunov, 2010, Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study, Lancet Neurol, 9, 986, 10.1016/S1474-4422(10)70197-6

van Es, 2009, Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis, Nat Genet, 41, 1083, 10.1038/ng.442

Andersen, 2011, Clinical genetics of amyotrophic lateral sclerosis: what do we really know?, Nat Rev Neurol, 7, 603, 10.1038/nrneurol.2011.150

Fahey, 2014, Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample, Neurobiol Aging, 35, 1510.e1, 10.1016/j.neurobiolaging.2013.12.003

Kertesz, 2013, Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort, Cogn Behav Neurol, 26, 146, 10.1097/WNN.0000000000000008

Hardy, 2014, Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not, Exp Neurol, 262, 75, 10.1016/j.expneurol.2013.11.006

Barbeito, 2010, Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS, Neurobiol Dis, 37, 574, 10.1016/j.nbd.2009.11.007

Kamel, 2008, Association of lead exposure with survival in amyotrophic lateral sclerosis, Environ Health Perspect, 116, 943, 10.1289/ehp.11193

Keren, 2014, Evidence of an environmental effect on survival in ALS, Amyotroph Lateral Scler Frontotemporal Degener, 15, 528, 10.3109/21678421.2014.911326

Eum, 2015, Modification of the association between lead exposure and amyotrophic lateral sclerosis by iron and oxidative stress related gene polymorphisms, Amyotroph Lateral Scler Frontotemporal Degener, 16, 72, 10.3109/21678421.2014.964259

Fogh, 2016, Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis, JAMA Neurol, 73, 812, 10.1001/jamaneurol.2016.1114

Alanazy, 2014, Diagnostic yield and cost-effectiveness of investigations in patients presenting with isolated lower motor neuron signs, Amyotroph Lateral Scler Frontotemporal Degener, 15, 414, 10.3109/21678421.2014.913635

Andersen, 2012, EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force, Eur J Neurol, 19, 360, 10.1111/j.1468-1331.2011.03501.x

Brooks, 2000, Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS. Versailles 2nd Consensus Conference participants, Amyotroph Lateral Scler Other Motor Neuron Disord, 1, S79, 10.1080/14660820050515629

Sanderson, 2015, The clinical spectrum of isolated peripheral motor dysfunction, Muscle Nerve, 51, 358, 10.1002/mus.24326

Donaldson, 2016, Clinical significance of cation channel antibodies in motor neuron disease, Muscle Nerve, 54, 228, 10.1002/mus.25046

Kollewe, 2015, Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited, PLoS ONE, 10, e0125339, 10.1371/journal.pone.0125339

Gaiottino, 2013, Increased neurofilament light chain blood levels in neurodegenerative neurological diseases, PLoS ONE, 8, e75091, 10.1371/journal.pone.0075091

Steinacker, 2016, Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients, J Neurol Neurosurg Psychiatry, 87, 12

Puentes, 2014, Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 85, 274, 10.1136/jnnp-2013-305494

Roche, 2012, A proposed staging system for amyotrophic lateral sclerosis, Brain, 135, 847, 10.1093/brain/awr351

Agosta, 2015, The El Escorial criteria: strengths and weaknesses, Amyotroph Lateral Scler Frontotemporal Degener, 16, 1, 10.3109/21678421.2014.964258

Spinelli, 2016, Brain MR imaging in patients with lower motor neuron-predominant disease, Radiology, 280, 545, 10.1148/radiol.2016151846

Brettschneider, 2013, Stages of pTDP-43 pathology in amyotrophic lateral sclerosis, Ann Neurol, 74, 20, 10.1002/ana.23937

Kassubek, 2014, Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology, Brain, 137, 1733, 10.1093/brain/awu090

Treede, 2015, A classification of chronic pain for ICD-11, Pain, 156, 1003, 10.1097/j.pain.0000000000000160

Rajakulendran, 2014, The classification of neurological disorders in the 11th revision of the International Classification of Diseases (ICD-11), J Neurol Neurosurg Psychiatry, 85, 952, 10.1136/jnnp-2013-307093

Rief, 2010, The need to revise pain diagnoses in ICD-11, Pain, 149, 169, 10.1016/j.pain.2010.03.006

Jette, 2015, ICD coding for epilepsy: past, present, and future—a report by the International League Against Epilepsy Task Force on ICD codes in epilepsy, Epilepsia, 56, 348, 10.1111/epi.12895

Stone, 2014, Functional disorders in the Neurology section of ICD-11: a landmark opportunity, Neurology, 83, 2299, 10.1212/WNL.0000000000001063

Statland, 2015, Patterns of weakness, classification of motor neuron disease, and clinical diagnosis of sporadic amyotrophic lateral sclerosis, Neurol Clin, 33, 735, 10.1016/j.ncl.2015.07.006

Statland, 2015, Primary lateral sclerosis, Neurol Clin, 33, 749, 10.1016/j.ncl.2015.07.007

Liewluck, 2015, Progressive muscular atrophy, Neurol Clin, 33, 761, 10.1016/j.ncl.2015.07.005

Jawdat, 2015, Amyotrophic lateral sclerosis regional variants (brachial amyotrophic diplegia, leg amyotrophic diplegia, and isolated bulbar amyotrophic lateral sclerosis), Neurol Clin, 33, 775, 10.1016/j.ncl.2015.07.003

First, 2015, The development of the ICD-11 Clinical Descriptions and Diagnostic Guidelines for Mental and Behavioural Disorders, World Psychiatry, 14, 82, 10.1002/wps.20189

Wagner, 2015, State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance, Amyotroph Lateral Scler Frontotemporal Degener, 1

Stein, 2016, The classification of Obsessive-Compulsive and Related Disorders in the ICD-11, J Affect Disord, 190, 663, 10.1016/j.jad.2015.10.061

Al-Chalabi, 2014, Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study, Lancet Neurol, 13, 1108, 10.1016/S1474-4422(14)70219-4

Balendra, 2015, Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials, J Neurol Neurosurg Psychiatry, 86, 45, 10.1136/jnnp-2013-306865

Chiò, 2015, Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 86, 38, 10.1136/jnnp-2013-306589